Phase Genomics is a University of Washington spinout organized around providing improved genome and metagenome assemblies. The firm is developing technology for ProxiMeta Hi-C genome assemby and metagenome deconvolution using leading-edge technology that exploits higher order DNA structure for improved genome and metagenome assembly. From chromosome-level genome scaffolding to assembling complete genomes from mixed populations, the firm's platform is designed to provide a rapid and affordable solution that yields unparalleled results - through more complete, affordable genomes, empowering scientists to answer biological questions not previously thought possible.